Genezen
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · Indiana, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9900 Westpoint Dr Ste 128, Indianapolis,...Website
www.genezen.comRevenue
$11.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Genezen
Genezen is a technical and quality-focused Contract Development and Manufacturing Organization (CDMO) specializing in viral vector manufacturing for cell and gene therapy developers. They offer a comprehensive range of services including AAV, lentiviral, and retroviral vector production, as well as plasmid design and cell therapy support. With state-of-the-art facilities in Indiana and Massachusetts, Genezen is dedicated to advancing innovative therapies from preclinical stages to GMP supply. Their collaborative project management approach ensures tailored support for clients aiming to bring their viral vector-based therapies to patients.Explore more
Genezen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genezen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Genezen has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Genezen has new funding data
Product Launch: Get notified when Genezen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Genezen is spiking on competitors!
Genezen, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Genezen had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Genezen
Earning: See what the market has to say on Genezen recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Genezen
Compare insights from companies similar to Genezen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genezen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genezen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genezen.
Genezen financials insights
Gather financial insights about Genezen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Private Equity
$18.5M
Genezen Tech Stack
A closer look at the technologies used by Genezen
See more technologies
Most Recent Scoops
Hiring Plans
Genezen has more open roles in Operations than it has had at any time in the past 6 months. Areas of expertise include: Continuous Improvement Process, Current Good Manufacturing Practices (cGMPS), Technical Leadership, Control Operation, Process Implementations, Purchasing, and Calibration.
Hiring Plans
Open Position
Open Position
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Genezen News & Media
Genezen Partners with Elly's Team on Development for AAV Serotype 9 Gene Replacement Therapy for NEDAMSS; Genezen CTO Dr. Susan D'Costa to join nonprofit's board
LEXINGTON, Mass. and NEW YORK, May 12, 2025 /PRNewswire/ -- Genezen, a leading gene therapy CDMO, has partnered with Elly's Team, a foundation dedicated to accelerating the translation of medical research into treatments, for an AAV9 gene replacement therapy targeting Neurodevelopmental...Genezen and Optieum Biotechnologies Partner to Support cGMP Manufacturing of Groundbreaking CAR-T Therapy for Glioblastoma
Collaboration supports manufacture of the OPTF01 product to Drive Next-Generation Chimeric Antigen Receptor T Cell (CAR-T) Development INDIANAPOLIS and EHIME, Japan, May 5, 2025 /PRNewswire/ -- Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and...Genezen Welcomes New Board Members | Contract Pharma
Taps the expertise of industry veterans Dr. Pam Stetkiewicz and Stuart Auerbach.Genezen Welcomes Industry Experts Dr. Pam Stetkiewicz and Stuart Auerbach to Board of Directors
BOSTON and INDIANAPOLIS, Nov. 7, 2024 /PRNewswire/ -- Genezen, a best-in-class gene therapy contract development and manufacturing organization (CDMO), is pleased to announce Dr. Pam Stetkiewicz and Stuart Auerbach have joined its Board of Directors. These board appointments bolster...
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genezen
Sign Up For FreeTo access detailed company insights
Genezen is a technical and quality-focused Contract Development and Manufacturing Organization (CDMO) specializing in viral vector manufacturing for cell and gene therapy developers. They offer a comprehensive range of services including AAV, lentiviral, and retroviral vector production, as well as plasmid design and cell therapy support. With stat... Read More
